Mycosis fungoides causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
Development of cutaneous T cell lymphoma is the result of multiple [[Genetics|genetic]] [[mutation]]<nowiki/>s. | Development of cutaneous T cell lymphoma is the result of multiple [[Genetics|genetic]] [[mutation]]<nowiki/>s. | ||
==Causes== | ==Causes== | ||
* The cause of | * The cause of mycosis fungoides has not been identified. However, there are certain risk factors that predisposes to risk of mycosis fungoides. | ||
* For more information on risk factors, [[Mycosis fungoides risk factors|click here]]. | |||
* Development of [[cutaneous T cell lymphoma]] is the result of multiple [[genetic mutations]].<ref name="ShinMonti2007">{{cite journal|last1=Shin|first1=J.|last2=Monti|first2=S.|last3=Aires|first3=D. J.|last4=Duvic|first4=M.|last5=Golub|first5=T.|last6=Jones|first6=D. A.|last7=Kupper|first7=T. S.|title=Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome|journal=Blood|volume=110|issue=8|year=2007|pages=3015–3027|issn=0006-4971|doi=10.1182/blood-2006-12-061507}}</ref><ref name="WongMishra2011">{{cite journal|last1=Wong|first1=Henry K.|last2=Mishra|first2=Anjali|last3=Hake|first3=Timothy|last4=Porcu|first4=Pierluigi|title=Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)|journal=British Journal of Haematology|volume=155|issue=2|year=2011|pages=150–166|issn=00071048|doi=10.1111/j.1365-2141.2011.08852.x}}</ref><ref name="Wilcox2011">{{cite journal|last1=Wilcox|first1=Ryan A.|title=Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management|journal=American Journal of Hematology|volume=86|issue=11|year=2011|pages=928–948|issn=03618609|doi=10.1002/ajh.22139}}</ref><ref name="Whittaker2006">{{cite journal|last1=Whittaker|first1=Sean|title=Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)|journal=Seminars in Oncology|volume=33|year=2006|pages=3–6|issn=00937754|doi=10.1053/j.seminoncol.2005.12.015}}</ref><ref>{{Cite journal | * Development of [[cutaneous T cell lymphoma]] is the result of multiple [[genetic mutations]].<ref name="ShinMonti2007">{{cite journal|last1=Shin|first1=J.|last2=Monti|first2=S.|last3=Aires|first3=D. J.|last4=Duvic|first4=M.|last5=Golub|first5=T.|last6=Jones|first6=D. A.|last7=Kupper|first7=T. S.|title=Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome|journal=Blood|volume=110|issue=8|year=2007|pages=3015–3027|issn=0006-4971|doi=10.1182/blood-2006-12-061507}}</ref><ref name="WongMishra2011">{{cite journal|last1=Wong|first1=Henry K.|last2=Mishra|first2=Anjali|last3=Hake|first3=Timothy|last4=Porcu|first4=Pierluigi|title=Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)|journal=British Journal of Haematology|volume=155|issue=2|year=2011|pages=150–166|issn=00071048|doi=10.1111/j.1365-2141.2011.08852.x}}</ref><ref name="Wilcox2011">{{cite journal|last1=Wilcox|first1=Ryan A.|title=Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management|journal=American Journal of Hematology|volume=86|issue=11|year=2011|pages=928–948|issn=03618609|doi=10.1002/ajh.22139}}</ref><ref name="Whittaker2006">{{cite journal|last1=Whittaker|first1=Sean|title=Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)|journal=Seminars in Oncology|volume=33|year=2006|pages=3–6|issn=00937754|doi=10.1053/j.seminoncol.2005.12.015}}</ref><ref>{{Cite journal | ||
| author = [[Henry K. Wong]] | | author = [[Henry K. Wong]] |
Revision as of 20:06, 28 January 2019
Mycosis fungoides Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mycosis fungoides causes On the Web |
American Roentgen Ray Society Images of Mycosis fungoides causes |
Risk calculators and risk factors for Mycosis fungoides causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sogand Goudarzi, MD [3]
Overview
Development of cutaneous T cell lymphoma is the result of multiple genetic mutations.
Causes
- The cause of mycosis fungoides has not been identified. However, there are certain risk factors that predisposes to risk of mycosis fungoides.
- For more information on risk factors, click here.
- Development of cutaneous T cell lymphoma is the result of multiple genetic mutations.[1][2][3][4][5]
References
- ↑ Shin, J.; Monti, S.; Aires, D. J.; Duvic, M.; Golub, T.; Jones, D. A.; Kupper, T. S. (2007). "Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome". Blood. 110 (8): 3015–3027. doi:10.1182/blood-2006-12-061507. ISSN 0006-4971.
- ↑ Wong, Henry K.; Mishra, Anjali; Hake, Timothy; Porcu, Pierluigi (2011). "Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)". British Journal of Haematology. 155 (2): 150–166. doi:10.1111/j.1365-2141.2011.08852.x. ISSN 0007-1048.
- ↑ Wilcox, Ryan A. (2011). "Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management". American Journal of Hematology. 86 (11): 928–948. doi:10.1002/ajh.22139. ISSN 0361-8609.
- ↑ Whittaker, Sean (2006). "Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)". Seminars in Oncology. 33: 3–6. doi:10.1053/j.seminoncol.2005.12.015. ISSN 0093-7754.
- ↑ Henry K. Wong (2013). "Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma". Discovery medicine. 16 (87): 71–78. PMID 23998443. Unknown parameter
|month=
ignored (help)